Bloomberg News

AMT Plans to Reduce Workforce by Half to 45 Full-Time Employees

October 25, 2011

Oct. 25 (Bloomberg) -- Amsterdam Molecular Therapeutics NV plans to cut its workforce by half to 45 full-time employees and suspended the development program of its main product Glybera as further investment is no longer tenable, the company said in a statement today on its website.

To contact the editor responsible for this story: Fred Pals at fpals@bloomberg.net


Coke's Big Fat Problem
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus